Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination

Scott, Jaime; Anderson, Jenna; Mallak, Nadine; Beitinjaneh, Bassel; Wei, Kevin; Otaki, Fouad

doi:10.14309/ajg.0000000000001354

Cited by 7 publications

(7 citation statements)

References 5 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 2 However, additional studies have found added reactions to COVID-19 vaccinations not limited to mRNA-1273, including pancreatitis, gastroparesis, autoimmune hepatitis, and IBD flare. 3 - 7 To the best of our knowledge, this is the first case of lymphocytic colitis that developed after COVID-19 vaccination. In this presentation, our patient at baseline had no gastrointestinal symptoms but after vaccination, developed loose stools that worsened to diarrhea with the second dose and was diagnosed with lymphocytic colitis.…”

Section: Discussionmentioning

confidence: 85%

See 1 more Smart Citation

De Novo Diagnosis of Lymphocytic Colitis After SARS-CoV-2 Vaccination

et al. 2022

View full text Add to dashboard Cite

SARS-CoV-2 mRNA vaccines are safe and effective for most patients. Gastrointestinal complications reported after vaccination have included gastroparesis and inflammatory bowel disease flares. In this study, we present a unique case of lymphocytic colitis that occurred in a healthy middle-aged man after Moderna SARS-CoV-2 mRNA vaccination. This reveals an unexpected complication of a mRNA vaccine that presented as worsening diarrhea after vaccination in a dose-dependent pattern. Caregivers should be aware of lymphocytic colitis as a possible complication of the Moderna vaccine and monitor those patients closely for symptom resolution.

show abstract

Section: Discussionmentioning

confidence: 85%

“…In addition, rare cases of gastroparesis, inflammatory bowel disease (IBD) flare, autoimmune hepatitis, and pancreatitis have been reported after vaccine administration. 3 – 7 We report the first diagnosis of lymphocytic colitis after SARS-CoV-2 vaccination.…”

Section: Introductionmentioning

confidence: 93%

De Novo Diagnosis of Lymphocytic Colitis After SARS-CoV-2 Vaccination

et al. 2022

View full text Add to dashboard Cite

show abstract

“…There are reports about gastroparesis manifested as nausea and vomiting following Pfizer vaccine administration. 31 The more frequent flu-like illness among Sinopharm receivers could be attributed to the faded effect of this vaccine among patients as explained earlier. Therefore, they were presented with this illness as a frequent symptom of COVID-19.…”

Section: Discussionmentioning

confidence: 86%

Charcterization of COVID-19 hospitalized adult patients, vaccinated vs non-vaccinated in Duhok province

Mohammed

Merza

2022

J. Contemp. Med. Sci.

View full text Add to dashboard Cite

Objectives: First, to determine prevalence of vaccinated COVID-19 patients among hospitalized patients; Second, to determine the epidemiological, clinical, and laboratory characteristics of vaccinated and unvaccinated COVID-19 patients. Methods: The study was carried out on 300 adult COVID-19 hospitalized patients at Duhok COVID-19 health facilities. A prospective cross-sectional study was used as the study design. Between October 1, 2021, and March 31, 2022, all patients with PCR-confirmed COVID-19 were enrolled. Results: The majority of people in this study were unvaccinated. Pfizer was most popular among people who had received vaccination. The majority of hospitalized patients were old ages, the mean age was 60.73 ± 15.83 yr. In our study, the unvaccinated females had higher infection rates while vaccinated males had higher hospital admission rates. In our study, vaccinated patients had shorter hospital duration stays. In both vaccinated and unvaccinated patients, predominated cases were severe cases. D dimer was significantly higher among vaccinated patients. The mortality rate was relatively high among both groups. Patients who had received vaccinations tended to experience vomiting and flu-like symptoms more frequently than those who had not. In terms of comorbidities, smoking and malignancy were significant risk factors for COVID-19 infection in unvaccinated patients. Conclusion: We looked at 300 COVID-19 hospitalized patients. In this study, the majority of people were unvaccinated. Pfizer, had higher prevalence among vaccinated individuals. Majority were elderly. The unvaccinated cases had a higher rate of female hospital admissions than male. The D.Dimer level was significantly different between the two groups. Vomiting and flu-like illness showed higher prevalence in vaccinated cases with significant difference. Smoking and malignancy were significant risk factors for COVID-19 infection in unvaccinated patients. In the fight against a public health disaster like a COVID-19 pandemic, the availability of a COVID-19 vaccines campaign are crucial.

show abstract

“…Gastroparesia é uma desordem caracterizada por retardo do esvaziamento gástrico na ausência de obstrução mecânica (Rusch et al, 2022;Scott et al, 2021). Esta entidade apresenta-se por náuseas, vômitos, dor abdominal, saciedade precoce e perda ponderal a longo prazo (Rusch et al, 2022;Scott et al, 2021).…”

Section: Introductionunclassified

Post-COVID refractory gastroparesis: a case report

Oliveira,

Ibiapina,

Reis

et al. 2023

CLIUM

View full text Add to dashboard Cite

Introduction: COVID-19 is a disease caused by the SARS-CoV-2 virus, which triggered a pandemic with major repercussions for the world's health systems. About half of patients experience gastrointestinal symptoms, but gastroparesis after SARS-CoV-2 infection is a rare and generally self-limiting condition. Objective: To describe a clinical case of gastroparesis after SARS-CoV-2 infection that required surgical intervention. Result: This is a rare condition, with few reports, generally self-limiting. There are no reports of other refractory conditions requiring surgical intervention. Conclusion: The COVID-19 pandemic resulted in a large number of patients infected with SARS-CoV-2. Because the virus has gastrointestinal tropism, doctors must be aware of possible clinical manifestations in these patients.

show abstract

Gastroparesis After Pfizer-BioNTech COVID-19 Vaccination

Cited by 7 publications

References 5 publications

De Novo Diagnosis of Lymphocytic Colitis After SARS-CoV-2 Vaccination

De Novo Diagnosis of Lymphocytic Colitis After SARS-CoV-2 Vaccination

Charcterization of COVID-19 hospitalized adult patients, vaccinated vs non-vaccinated in Duhok province

Post-COVID refractory gastroparesis: a case report

Contact Info

Product

Resources

About